Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases

Clinical trial NCT02145910 · WITHDRAWN

Trial details

NCT number: NCT02145910
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IV Melanoma Tumors Metastatic to Brain

Primary completion: 2019-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.